United Therapeutics (UTHR) Preferred Stock Liabilities (2012 - 2019)

United Therapeutics has disclosed Preferred Stock Liabilities across 8 years of filings, most recently posting $8.4 million for Q2 2019.

• In Q2 2019, Preferred Stock Liabilities fell 56.25% year-over-year to $8.4 million; the TTM figure through Jun 2019 stood at $8.4 million (down 56.25% YoY), while the FY2018 annual figure was $19.2 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $8.4 million for Q2 2019 at United Therapeutics, down from $19.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $20.4 million in Q1 2015 to a low of $8.4 million in Q2 2019.
• Average Preferred Stock Liabilities over 5 years is $15.2 million, with a median of $16.1 million recorded in 2015.
• Year-over-year, Preferred Stock Liabilities sank 66.6% in 2015 and soared 76.15% in 2017.
• Over 5 years, Preferred Stock Liabilities stood at $11.1 million in 2015, then declined by 1.8% to $10.9 million in 2016, then soared by 76.15% to $19.2 million in 2017, then changed by 0.0% to $19.2 million in 2018, then sank by 56.25% to $8.4 million in 2019.
• Per Business Quant data, the three most recent Preferred Stock Liabilities figures were $8.4 million in Q2 2019, $19.2 million in Q1 2019, and $19.2 million in Q4 2018.